BANGKOK GENOMICS INNOVATION PLC.

BANGKOK GENOMICS INNOVATION PLC. Generally speaking is a biotechnology company. it's neither a traditional factory mass-producing generic goods nor solely a trading company. For example It functions as a specialized developer and manufacturer of cutting-edge biotechnological items, such as diagnostic kits and reagents, and a provider of high-tech laboratory services. Company Introduction:

environment of Business:

BANGKOK GENOMICS INNOVATION PLC. is a leading biotechnology firm specializing in genomics and precision medicine. The company is dedicated to improving general health through cutting-edge genetic testing, genomic sequencing, and bioinformatics analysis. Core Activities and Services:

Genomic Sequencing: Providing thorough sequencing services to various applications, including whole genome, exome, and targeted sequencing. Genetic Testing: Offering a wide range of clinical diagnostic tests, such as non-invasive prenatal testing (NIPT), carrier screening, pharmacogenomics, and inherited disease screening. is able tocer Genomics: Developing and providing solutions to is able tocer risk assessment, diagnosis, prognosis, and personalized treatment guidance. I've found that Research and research: Engaging in continuous innovation to develop new genomic technologies, diagnostic platforms, and bioinformatics tools. Bioinformatics and Data Analysis: Offering expert analysis and interpretation of complex genomic data to facilitate research and clinical decision-making. Overall Focus:

The company's mission is to leverage cutting-edge genomic science to deliver accurate, reliable, and actionable insights, contributing to personalized healthcare and scientific advancement in Thailand and the wider region.

BANGKOK GENOMICS INNOVATION PLC. (BKGI) primarily focuses on providing:

* **Genomic sequencing services**

* **Genetic testing services**

* **Bioinformatics analysis services**

* **Reproductive health solutions (NIPT)**

* **Cancer screening and diagnosis services**

* **Research and development in genomics**